Biotech, Healthcare & Wellness



XPhyto Therapeutics Corp.
Latest Comments
image_pdfimage_print

MedX Health’s global sales team discuss the commercialization of their teledermatology screening platform across North America, Europe and the Middle East

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services, Naman Demaghlatrous, Managing Director, Europe, […]


MedX Health’s teledermatology platform brings healthcare to the fingertips of patients

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services and Naman Demaghlatrous, Managing Director, […]


Sona Nanotech is seeking U.S. FDA approval for its rapid COVID-19 saliva test

Much to my chagrin, it appears this damn COVID virus is refusing to let us be. I guess one positive […]


The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease

Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage disease is […]


MedX Health’s SIAscopy®, The Future of Remote Dermatological Diagnosis has Arrived

The Covid pandemic has certainly resulted in one positive thing – It has been instrumental in advancing numerous technologies. Perhaps […]


Zentek is well positioned to commercialize several revolutionary nanotech graphene health products in 2022

Zentek Ltd. (TSXV: ZEN) (formerly ZEN Graphene Solutions Ltd.) is a trail blazing company in the world of  nanotechnology and […]


Chris Thompson on eResearch’s Update Equity Research Report on XORTX Therapeutics Inc.

In a recent InvestorIntel interview, Tracy Weslosky spoke with Chris Thompson, President of eResearch Corp. about his 25-page Update Equity Research […]


XPhyto Therapeutics Corp.